TY  - JOUR
T1  - Leucocyte Variation During Human Menopausal Gonadotrophin (Pergonal<SUP>&reg;</SUP>) and Prostaglandin Treatment in West African Dwarf Goats
AU - , A.H. Abu AU - , F.C. Iheukwumere AU - , E.C. Ndubisi AU - , U.N. Egu 
JO  - Journal of Animal and Veterinary Advances
VL  - 7
IS  - 1
SP  - 32
EP  - 34
PY  - 2008
DA  - 2001/08/19
SN  - 1680-5593
DO  - javaa.2008.32.34
UR  - https://makhillpublications.co/view-article.php?doi=javaa.2008.32.34
KW  - Human menopausal gonadotrophin
KW  -prostaglandin
KW  -leucocyte
KW  -goats
AB  - A total of 24  matured, parous, clinically sound West African dwarf goats aged 3-5 years were used to study the effect of human menopausal gonadotrophin (Pergonal<SUP>&reg;</SUP>) and prostaglandin on leucocyte variations. The goats were divided into three groups of eight goats in each group identified as T<SUB>1</SUB> (Control), T<SUB>2</SUB> human menopausal gonadotrophin treated goats, T<SUB>3</SUB> prostaglandin treated goats. The results show that total leucocyte count consistently increased from pre-treatment to 48 h post-oestrus in HMG-treated goats. There was no significant difference (p&gt;0.05) in Dinoprost tromethiamine induced and natural oestrus. Neutrophil percentage was  more  during superovulatory oestrus followed by pre-treatment value. However, lymphocyte value was high  during  48 h. Superovulatory oestrus, whereas in Dinoprost treated groups neutrophil was more during pre-treatment, but the difference was not significant (p&gt;0.05) between treatment groups. The monocyte, eosinophil and basophil values were similar (p&gt;0.05). The results of this study, indicate that HMG and prostaglandin treatments were not detrimental to the leucocyte count of goats.
ER  -